Beijing Shihong Pharmaceutical Center

Beijing Shihong Drug Research Center is a specialized pharmaceutical enterprise based in China, focusing on the development of treatments for chronic liver diseases and cancer. The company is recognized for its integration of Traditional Chinese Medicine (TCM) with modern drug delivery and pharmacological standards. Its flagship product line, the Shihong series, is widely used in China for managing chronic Hepatitis B and preventing the progression of liver cirrhosis to malignancy. The center maintains its own research and production base in Beijing, emphasizing immunomodulatory mechanisms in its therapeutic approach to chronic viral infections and oncology.